tisotumab

FDA Drug Profile

Drug Details

Generic Name
tisotumab
Brand Names
N/A
Application Number
Sponsor
Lonza Biologics, plc
NDC Codes
1
Dosage Forms
LIQUID
Routes
N/A
Active Ingredients
TISOTUMAB

Indications and Usage

1 INDICATIONS AND USAGE TIVDAK ® is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. TIVDAK is a tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. ( 1 )